Aphasia, Stroke
Conditions
Keywords
tDCS, aphasia
Brief summary
The purpose of this study is to investigate effects of tDCS stimulation in the left primary motor area followed by naming therapy to improve language functions in patients with aphasia in the sub-acute stage.
Detailed description
Transcranial Direct Current Stimulation (tDCS) is a simple and non-intrusive method that has demonstrated promising results in language rehabilitation of patients with aphasia. Various studies have used different stimulation set-ups, some based on prior structural and functional brain mapping in order to choose the optimal stimulation region. An additional approach that was found beneficial is stimulation of the left primary motor area (M1). A major advantage of this approach is its relative simplicity that may increase the application of this intervention in clinical settings. This intervention approach has been studied in patients with chronic aphasia and targeted on naming ability. In the current study the investigators aim to study the influence of a stimulation set-up at M1 in stroke patients suffering from aphasia that are in the sub-acute stage. In addition the investigators aim to study additional language functions including pragmatics and grammar. The study will include 30 patients suffering from aphasia which are in the sub-acute stage. The patients will undergo complete language assessments at 3 time points: baseline, post intervention (third week from recruitment) and one month follow-up. The study group will include 15 patients that will undergo TDCS at the left M1 region followed by naming therapy. The intervention will be given daily for duration of two weeks (5 days/week). The control group will include 15 patients that will undergo the same protocol apart from sham TDCS. The effect of the intervention will be examined taking into account the extent and location of the brain damage on language functions.
Interventions
DEVICEexperimental: tDCS
The anode will be placed over the left M1 representation of the hand (C3 of the 10-20 EEG system). Twenty minutes of anodal-tDCS (1mA) will be administered at the beginning of the daily treatment session. Following the stimulation will be 45 minutes of naming therapy.
DEVICEsham tDCS
The anode will be placed over the left M1 representation of the hand (C3 of the 10-20 EEG system). Twenty minutes of sham-tDCS will be administered at the beginning of the daily treatment session. During sham-tDCS, the current will be ramped up and remained at 1mA only for 30 s before ramping down, which does not affect neural functions, but assures effective blinding of participants due to the initial tingling sensation on the scalp. Following the sham stimulation will be 45 minutes of naming therapy.
Sponsors
Nachum Soroker, MD
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* patients post stroke with right hemiplegia and aphasia with cognitive capacity to understand instructions and at the aphasia cut-of level defined by SHEMESH assessment
Exclusion criteria
* unstable clinical state, craniotomy, epilepsy, heart pacer or lack of cooperation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Shemesh 100 nouns test (Biran and Friedmann 2005) | baseline (before intervention), post intervention (on the third week from recruitment) and one month follow-up. | language test |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Western Aphasia Battery Hebrew | baseline (before intervention), post intervention (on the third week from recruitment) and one month follow-up. | aphasia assessment |
| Change in Psycholinguistic Assessments of Language Processing in Aphasia | baseline (before intervention), post intervention (on the third week from recruitment) and one month follow-up. | psycholinguistical assessment of aphasia |
Contacts
Primary ContactNachum Soroker, M.D
Backup ContactCorinne R Zarfati, M.D.
Outcome results
None listed